# Effect of CYP2C9/CYP2C19 Polymorphism on Pharmacokinetics of Phenobarbital in Korean Neonatal Seizure Patients.

> **NCT01224457** · NA · COMPLETED · sponsor: **Yonsei University** · enrollment: 52 (actual)

## Conditions studied

- Neonatal Seizure

## Interventions

- **DRUG:** Phenobarbital

## Key facts

- **NCT ID:** NCT01224457
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2010-04
- **Final completion:** 2010-05
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2012-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01224457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01224457, "Effect of CYP2C9/CYP2C19 Polymorphism on Pharmacokinetics of Phenobarbital in Korean Neonatal Seizure Patients.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01224457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*